Invascent Capital, an Indian healthcare-focused GP, has closed its third vehicle at the hard cap of $250 million.
India Life Sciences Fund III (ILSF III) was oversubscribed, Invascent Managing Director Hari Buggana told AVCJ, and has already made three investments. Last year the firm acquired a stake in pharmaceutical...
Xyb2b.com, a B2B platform that helps Chinese e-commerce companies source products from overseas, has completed an extended Series B round of funding worth $100 million.
Beijing Ubox Online Technology, a Chinese vending machine manager, has received RMB1.6 billion ($226 million) in funding from Ant Financial Services Group and Primavera Capital Group.
CITIC Capital has scaled up for its latest China fund, raising 75% more capital than in the previous vintage. The buyout-focused GP expects tighter liquidity to drive more corporate carve-outs
Tala, a US financial technology provider looking to expand its microlending operations in India, has raised a $110 million Series D round from a group including PayPal Ventures.